Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Mesoblast Ltd.

WKN: A0DNPW / Name: Mesoblast / Stock / Biotechnology & Medical Research / Small Cap /

?
-1.950%

0 0
0
0
Mesoblast Ltd.

WKN: A4004R / Name: Mesoblast Ltd. / Stock / ? /

€14.50
9.850%

0 0
0
0
MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up
MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up

Mesoblast Limited MESO announced that it has completed patient treatment in a pivotal phase III MSB-DR004 study, evaluating its pipeline candidate, rexlemestrocel-L, for treating chronic low back

Zacks 
0 18.08.26